Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.
Domingo E. et al, (2024), Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
Challoner BR. et al, (2023), The Journal of pathology
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.
Frei AL. et al, (2023), The journal of pathology. Clinical research
Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis
Brown M. et al, (2023), EMBO Molecular Medicine
More than just a hangover – alcohol and carcinogenesis in Lynch syndrome
Church DN., (2023), Disease Models & Mechanisms, 16
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma.
Taylor CA. et al, (2022), Nat Med
CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.
Saunders MP. et al, (2022), ESMO open, 7
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.
RAINBO Research Consortium None., (2022), International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.
Vermij L. et al, (2022), Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 35, 1475 - 1483
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.
Kleppe A. et al, (2022), The Lancet. Oncology, 23, 1221 - 1232
Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape
Glaire MA. et al, (2022), The Journal of Pathology, 257, 340 - 351
Germline MBD4 deficiency causes a multi-tumor predisposition syndrome.
Palles C. et al, (2022), American journal of human genetics, 109, 953 - 960
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.
Horeweg N. et al, (2022), Nature communications, 13
Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.
Reijns MAM. et al, (2022), Nature, 602, 623 - 631
Histological and Somatic Mutational Profiles of Mismatch Repair Deficient Endometrial Tumours of Different Aetiologies.
Ryan NAJ. et al, (2021), Cancers, 13
Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer.
Jiang D. et al, (2021), EBioMedicine, 71
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
McAlpine JN. et al, (2021), Cancer, 127, 2409 - 2422
Promises and challenges of adoptive T-cell therapies for solid tumours
Morotti M. et al, (2021), British Journal of Cancer, 124, 1759 - 1776